Dashboard
Manage Tickers

MRNA Moderna, Inc.

Nasdaq modernatx.com


$ 24.53 $ 0.00 (0 %)    

Thursday, 20-Nov-2025 09:25:32 EST
CLICK TO SEE RELEVANT LITIGATION UPDATES
QQQ $ 612.00 $ 0.00 (0 %)
DIA $ 466.66 $ 0.00 (0 %)
SPY $ 673.28 $ 0.00 (0 %)
TLT $ 88.94 $ 0.00 (0 %)
GLD $ 375.55 $ 0.00 (0 %)
$ 24.18
$ 24.95
$ 24.52 x 11
$ 24.63 x 5
-- - --
$ 23.04 - $ 48.92
9,400,507
na
9.45B
$ 1.11
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-06-2025 09-30-2025 10-Q
2 08-01-2025 06-30-2025 10-Q
3 05-01-2025 03-31-2025 10-Q
4 02-21-2025 12-31-2024 10-K
5 11-07-2024 09-30-2024 10-Q
6 08-01-2024 06-30-2024 10-Q
7 05-02-2024 03-31-2024 10-Q
8 02-23-2024 12-31-2023 10-K
9 11-03-2023 09-30-2023 10-Q
10 08-03-2023 06-30-2023 10-Q
11 05-04-2023 03-31-2023 10-Q
12 02-24-2023 12-31-2022 10-K
13 11-03-2022 09-30-2022 10-Q
14 08-03-2022 06-30-2022 10-Q
15 05-04-2022 03-31-2022 10-Q
16 02-25-2022 12-31-2021 10-K
17 11-04-2021 09-30-2021 10-Q
18 08-05-2021 06-30-2021 10-Q
19 05-06-2021 03-31-2021 10-Q
20 02-26-2021 12-31-2020 10-K
21 10-30-2020 09-30-2020 10-Q
22 08-06-2020 06-30-2020 10-Q
23 05-07-2020 03-31-2020 10-Q
24 02-27-2020 12-31-2019 10-K
25 11-06-2019 09-30-2019 10-Q
26 08-08-2019 06-30-2019 10-Q
27 05-09-2019 03-31-2019 10-Q
28 03-13-2019 12-31-2018 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

moderna-improves-2026-and-2027-expected-gaap-operating-expenses-by-05b-each-year-on-path-to-targeted-cash-breakeven-in-2028
Moderna Improves 2026 And 2027 Expected GA...
11/20/2025 12:11:47

moderna-expects-to-expand-seasonal-vaccine-franchise-from-three-to-up-to-six-approved-products-by-2028
Moderna Expects To Expand Seasonal Vaccine...
11/20/2025 12:09:32

moderna-announces-3-yr-business-strategy-and-commercial-growth-drivers-targeting-up-to-10-revenue-growth-in-2026
Moderna Announces 3-Yr Business Strategy A...
11/20/2025 12:08:50

moderna-closes-5-yr-term-loan-facility-for-up-to-15b-of-capital-from-ares-management-credit-funds
Moderna Closes 5-Yr Term Loan Facility For...
11/20/2025 12:07:06

Non-dilutive financing from premier lender bolsters strong balance sheet and provides increased flexibilityCompany reiterates 2...

moderna-expands-us-manufacturing-capabilities-with-onshoring-of-drug-product-manufacturing-to-existing-moderna-technology-center-in-norwood-massachusetts
Moderna Expands U.S. Manufacturing Capabil...
11/19/2025 12:08:30

New capabilities strengthen U.S. production, completing Moderna's domestic end-to-end mRNA manufacturing networkMore than $...

merck-makes-big-bet-on-flu-protection-with-cidara-buyout
Merck Makes Big Bet On Flu Protection With...
11/14/2025 14:32:24

Merck (NYSE: MRK) to acquire Cidara (NASDAQ: CDTX) for $9.2 billion, diversifying its portfolio with CD388.

b-of-a-securities-maintains-underperform-on-moderna-lowers-price-target-to-21
B of A Securities Maintains Underperform o...
11/10/2025 12:11:57

B of A Securities analyst Dimple Gosai maintains Moderna (NASDAQ:MRNA) with a Underperform and lowers the price target from ...

barclays-maintains-equal-weight-on-moderna-lowers-price-target-to-25
Barclays Maintains Equal-Weight on Moderna...
11/07/2025 15:39:51

Barclays analyst Gena Wang maintains Moderna (NASDAQ:MRNA) with a Equal-Weight and lowers the price target from $31 to $25.

ai-stocks-slide-again-bitcoin-dips-near-100000-whats-moving-markets-thursday
AI Stocks Slide Again, Bitcoin Dips Near $...
11/06/2025 17:45:11

After a brief and cautious rebound on Wednesday, risk-off sentiment returned sharply on Thursday, with AI-linked stocks leading...

mrna-vaccine-maker-moderna-lowers-rd-spending-tightens-sales-forecast
mRNA Vaccine Maker Moderna Lowers R&D Spen...
11/06/2025 17:29:25

Moderna posts a smaller Q3 loss, trims 2025 sales forecast, cuts R&D costs, and boosts cash outlook as COVID vaccine demand...

moderna-q3-2025-earnings-call-transcript
Moderna Q3 2025 Earnings Call Transcript
11/06/2025 17:08:17

Moderna reported third-quarter financial results on Thursday. The transcript from the company's earnings call has been prov...

moderna-narrows-fy2025-sales-guidance-from-1500b-2200b-to-1600b-2000b-vs-1899b-est
Moderna Narrows FY2025 Sales Guidance from...
11/06/2025 12:02:42

Moderna (NASDAQ:MRNA) narrows FY2025 sales outlook from $1.500 billion-$2.200 billion to $1.600 billion-$2.000 billion vs $1.89...

moderna-q3-eps-051-beats-202-estimate-sales-1016b-beat-886539m-estimate
Moderna Q3 EPS $(0.51) Beats $(2.02) Estim...
11/06/2025 12:02:07

Moderna (NASDAQ:MRNA) reported quarterly losses of $(0.51) per share which beat the analyst consensus estimate of $(2.02) by 74...

earnings-scheduled-for-november-6-2025
Earnings Scheduled For November 6, 2025
11/06/2025 11:12:19

Core News & Articles
10 Health Care Stocks Whale Activity In To...
11/05/2025 17:35:20

moderna-stock-is-sliding-monday-whats-going-on
Moderna Stock Is Sliding Monday: What's Go...
11/03/2025 20:54:35

Moderna stock is trading sharply lower Monday afternoon as recent clinical setbacks overshadowed positive pipeline news.

Core News & Articles
10 Health Care Stocks Whale Activity In To...
11/03/2025 17:35:20

top-stocks-with-earnings-this-week-joby-ionq-amd-and-more
Top Stocks With Earnings This Week: Joby, ...
11/03/2025 14:14:07

Retail investors are preparing for another busy week of earnings season with more than 1,600 companies set to report through Fr...

moderna-has-dosed-the-first-patient-in-a-phase-12-study-of-mrna-2808-the-companys-investigational-mrna-based-t-cell-engager-for-relapsed-or-refractory-multiple-myeloma
Moderna Has Dosed The First Patient In A P...
11/03/2025 12:08:37

moderna-mrna-stock-is-trading-lower-friday-whats-going-on
Moderna (MRNA) Stock Is Trading Lower Frid...
10/31/2025 19:57:43

Moderna shares are trading lower Friday afternoon, giving back a portion of gains seen Thursday.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION